Speakers

OmniaBio

Gold Sponsor

OmniaBio Inc. is a subsidiary of CCRM. OmniaBio’s facility will be Canada’s first and largest commercial-scale CDMO dedicated to cell and gene therapies. Located at McMaster Innovation Park in Hamilton, Ontario, OmniaBio will anchor a biomanufacturing centre of excellence and will open in three phases between 2024 and 2026. Benefitting from CCRM’s existing expertise and established business practices, OmniaBio will complete CCRM’s continuum of process development and manufacturing capabilities by enabling focused support for clients with late clinical phase and commercial supply needs. OmniaBio is supported by the Government of Ontario, via the Invest Ontario Fund. Visit us at omniabio.com.

Speakers

ScaleReady

Gold Sponsor & Exhibitor

ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processingScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. 

Speakers

Resilience

Gold Sponsor & Exhibitor

Despite the explosive innovation in therapeutic discovery and development, biomanufacturing innovation and platforms have not kept pace. We intend to change that.

Resilience is a first-of-kind technology-based manufacturing company dedicated to broadening access to complex medicines and protecting biopharmaceutical supply chains from disruption. Founded in 2020, the Company is building a network of high-tech biomanufacturing platforms and capacity to ensure the medicines of today and tomorrow can be made at the quality, cost, and scale to meet patient needs. Resilience offers solutions for cell and gene therapy services from early clinical through commercial manufacturing including: process and analytical development, cell banking, viral vector production (AAV, LVV, and other viral vectors, immunotherapies, HSCs, iPSCs, and regenerative medicines). We are continuously advancing the science and technology of CGT biomanufacturing by investing heavily in R&D, manufacturing platforms and infrastructure. We focus on deep-rooted partnerships and novel business models. Resilience aims to free its partners’ time and resources to focus on therapeutic discoveries that improve patients’ lives and democratize access to medicines.

For more information, visit www.Resilience.com.

Speakers

WuXi Advanced Therapies

Platinum Sponsor

WuXi Advanced Therapies is a global Contract Testing Development and Manufacturing Organisation (CTDMO) headquartered in Philadelphia, USA,

in the heart of the cell and gene therapy industry. It is the advanced therapies business unit of WuXi AppTec and provides innovative technology platforms for lentiviral and AAV plasmid, viral vector and cell therapy manufacture and testing, accelerating time to market for cell and gene therapies.

We are a comprehensive provider of viral vector and cell therapy testing for the advanced therapy industry, conducting testing for both therapeutics developers

and other CDMOs. With OXGENE as our UK-based discovery engine, our in-house testing capabilities and significant manufacturing expertise combine to provide a fully integrated end-to-end solution for cell and gene therapy research, development, testing and GMP manufacture that delivers a critical competitive advantage to our customers as we work together to cure faster and cure more.

Speakers

Invetech

Gold Sponsor & Exhibitor

Invetech helps cell and gene therapy developers to visualize, strategize and manage the future. With proven processes, expert insights and full-spectrum services, we swiftly accelerate life-changing therapies from clinical to commercial-scale manufacturing. With configurable technology platforms and automated production systems, we enable predictable, reproducible products of the highest quality and efficacy. Our integrated approach brings together biological scientists, engineers, designers and program managers to deliver successful market offerings to more people globally. Working in close collaboration with early-stage and mature life science companies, we are committed to advancing the next generation of vital, emerging therapies to revolutionize healthcare and precision medicine.

Speakers

Cytiva

Gold Sponsor & Exhibitor

 At Cytiva, we believe the key to transforming human health is accessing life-changing therapies. That’s why our 10,000+ associates in more than 40 countries are keenly focused on helping researchers, biopharma companies, and drug manufacturers to advance and accelerate therapeutics for people that need them. We’re driven by their desire to achieve better flexibility, capacity, and efficiency in all facets of their work – all the way from idea to injection. Learn more at www.cytiva.com 

Speakers

Be The Match BioTherapies

Gold Sponsor & Exhibitor

Be The Match BioTherapies is the only cell and gene therapy solutions provider with customizable services to support the end-to-end cell therapy supply chain. Backed by the industry-leading experience of the National Marrow Donor Program (NMDP)®/Be The Match®, and a research partnership with the CIBMTR® (Center for International Blood and Marrow Transplant Research®), the organization designs solutions that advance the development of cell and gene therapies across the globe.

Be The Match BioTherapies is dedicated to accelerating patient access to life-saving cell and gene therapies by providing high-quality cellular source material from the Be The Match Registry®, the world’s largest and most diverse registry of more than 9 million potential blood stem cell donors in the U.S. with access to up to 39 million potential donors worldwide. Through established relationships with apheresis, marrow collection and transplant centers worldwide, the organization develops, onboards, trains and manages expansive collection networks to advance cell therapies.

Be The Match BioTherapies uses proven infrastructure consisting of regulatory compliance and managed logistics experts, as well as cell therapy supply chain case managers to successfully transport and deliver regulatory compliant life-saving therapies across the globe. Through the CIBMTR, Be The Match BioTherapies extends services beyond the cell therapy supply chain to include long-term follow-up tracking for the first two FDA-approved CAR-T therapies.

Speakers

Adva Biotechnology

Silver Sponsor & Exhibitor

ADVA Biotechnology is focused on developing and selling enabling technologies for cell therapy manufacturing. Established by a group of cell therapy and engineering experts with a vision of Valuing Life and Granting life-saving technologies to patients.

The ADVA X3 is a fully automated, simple, flexible, closed, and controlled manufacturing platform, for autologous cell therapies. The system efficiently manufactures therapies such as CAR-T, TCR, NK, TILs, Viruses and Exosomes. The platform controls 14 different parameters utilizing machine learning and AI, enabling a full process, from 20 million cells to 20 billion cells in one chamber, resulting in higher quality, cost efficient and decentralized manufacturing.

Speakers

Sony Biotechnology Inc

Gold Sponsor & Exhibitor
Speakers

PBS Biotech

Gold Sponsor & Exhibitor

PBS Biotech, Inc. manufactures the most advanced single-use bioreactors for the rapidly emerging cell and gene therapy market. Innovative Vertical-WheelTM mixing technology provides the benefits of complete particle suspension with low power input, homogeneous dissipation energy distribution, and minimal hydrodynamic shear stress. With unparalleled scalability across a full range of vessel sizes, Vertical-Wheel bioreactors enable high-quality and efficient manufacturing of cell and gene therapy products, from research to clinical and commercial scale. PBS Biotech also offers industry-leading contract research and process development services for a variety of cell and gene therapy applications.